ADAM17

Disintegrin and metalloproteinase domain-containing protein 17 · P78536 · ADAM17 on Sugi Atlas →

84,865 patent compounds predicted against ADAM17, 50,692 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Marimastat Marimastat (SCHEMBL34033) 1.00 13/20
Marimastat Marimastat (SCHEMBL134999) 1.00 13/20
Prinomastat Prinomastat (SCHEMBL115696) 1.00 12/20
SCHEMBL26484 SCHEMBL26484 1.00 10/20
SCHEMBL136238 SCHEMBL136238 1.00 10/20
SCHEMBL136239 SCHEMBL136239 1.00 10/20
SCHEMBL25833 SCHEMBL25833 1.00 9/20
SCHEMBL138143 SCHEMBL138143 1.00 9/20
SCHEMBL138144 SCHEMBL138144 1.00 9/20
SCHEMBL421106 SCHEMBL421106 0.47 8/20
SCHEMBL58761 SCHEMBL58761 0.39 8/20
SCHEMBL58754 SCHEMBL58754 0.35 8/20
SCHEMBL58755 SCHEMBL58755 0.35 8/20
SCHEMBL58126 SCHEMBL58126 0.34 8/20
SCHEMBL88914 SCHEMBL88914 0.33 8/20
SCHEMBL56831 SCHEMBL56831 0.50 7/20
SCHEMBL88936 SCHEMBL88936 0.32 7/20
SCHEMBL57913 SCHEMBL57913 0.31 7/20
SCHEMBL88598 SCHEMBL88598 0.31 7/20
SCHEMBL58365 SCHEMBL58365 0.41 6/20

Clinical trials — most relevant to ADAM17 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Estimation of MMP-8 Levels in GCF and Serum and Its Correlation With Wound Healing and Clinical Outcomes After Coronally Advanced Flap and Subepithelial Connective Tissue Graft for Root Coverage in Recession Defects: A CLINICO-BIOCHEMICAL STUDY PHASE4SUSPENDED
Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment PHASE3NOT_YET_RECRUITING
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast PHASE2COMPLETED
The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement PHASE1COMPLETED
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer PHASE1COMPLETED
Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction nanCOMPLETED
Exercise and the Receptor for Advanced Glycation End Products (RAGE) nanCOMPLETED
Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in Preeclampsia nanUNKNOWN
Infection, Sepsis and Meningitis in Surinamese Neonates nanCOMPLETED
Evaluation of Different Serum Cartilage Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Subjects nanAVAILABLE
Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development nanCOMPLETED
Apoptotic Changes in Gingiva Caused by Smoking nanCOMPLETED
Influence of Statins in Artery Aneurysms nanUNKNOWN
Salivary Markers in Periodontal Disorders nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma nanUNKNOWN
Sirtuin1 in COVID19 Patients nanUNKNOWN
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy nanCOMPLETED
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients nanCOMPLETED
Periodontal Health in Post COVID-19 Patients nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma nanCOMPLETED
Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA nanUNKNOWN
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence nanWITHDRAWN
Peri-implantitis and MMP-8 nanCOMPLETED
Utility of Presepsin in Children Sepsis nanUNKNOWN
Biomarkers in Post Thrombotic Syndrome nanCOMPLETED
Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial nanCOMPLETED
Disorders of the Acute Phase Response Following Trauma and Invasive Surgery nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a ADAM17 binder may also engage these)

ProteinNameSimilarity
Q9Z1K9 1.000 Q9Z1K9 →
Q9Z0F8 1.000 Q9Z0F8 →
O77636 1.000 O77636 →
O77633 0.995 O77633 →
G5EDW5 0.993 G5EDW5 →
ADAM10 Disintegrin and metalloproteinase domain-containing protein 10 0.993 landscape →
Q10743 0.993 Q10743 →
Q8JIY1 0.993 Q8JIY1 →
Q94316 0.993 Q94316 →
Q10741 0.992 Q10741 →
Q5W7F3 0.992 Q5W7F3 →
O35598 0.991 O35598 →
Q93105 0.990 Q93105 →
G5EFD9 0.990 G5EFD9 →
P86392 0.990 P86392 →
O18016 0.990 O18016 →
B5AJT4 0.989 B5AJT4 →
G5EFD5 0.989 G5EFD5 →
G5ECS8 0.989 G5ECS8 →
B5AJT3 0.989 B5AJT3 →
D5FM37 0.988 D5FM37 →
V9ZAY0 0.988 V9ZAY0 →
O73798 0.988 O73798 →
O35312 0.987 O35312 →
Q8BH35 0.987 Q8BH35 →
E9Q6D8 0.987 E9Q6D8 →
B4F6N6 0.987 B4F6N6 →
Q20930 0.987 Q20930 →
Q8W4J3 0.987 Q8W4J3 →
Q9WTR0 0.987 Q9WTR0 →